← Leaderboards
Zhengfeng Zhou
Oregon Health And Science University
$7,544,908
Attributed
$7,544,908
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $460.9K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,544,908 · 2
By mechanism
R01$7,544,908 · 2
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- James G Maylie$5,352,104
- Richard Gerald Brennan$7,274,596
Others in their field
Top investigators on “Long Qt Syndrome”
- Dan M Roden · Vanderbilt University Medical Center$24,202,957
- Alfred L George · Vanderbilt University$22,284,132
- Gideon Koren · Brigham And Women'S Hospital$21,067,576
- Robert S Kass · Columbia University Health Sciences$10,862,791
- Charles R Sanders · Vanderbilt University$9,888,145
- Arthur J. Moss · University Of Rochester$8,897,096
Research focus
Long Qt SyndromeGenesIntronsMutationRna SplicingHeartArrhythmiaCardiacCardiac MyocytesMrna PrecursorProteinsEthersAction PotentialsGenotypeNovel TherapeuticsPlayPolyadenylationFunctional DisorderGene MutationPathogenesisPhenotypeC-TerminalElectrocardiogramLead
Grant awards (21)
Post-transcriptional regulation of Kv11.1 (hERG) channel expression by alternative splicing and polyadenylation$460,880
R01 · FY2025 · HL · contact PI
Post-transcriptional regulation of Kv11.1 (hERG) channel expression by alternative splicing and polyadenylation$451,664
R01 · FY2024 · HL · contact PI
Post-transcriptional regulation of Kv11.1 (hERG) channel expression by alternative splicing and polyadenylation$460,880
R01 · FY2023 · HL · contact PI
Post-transcriptional regulation of Kv11.1 (hERG) channel expression by alternative splicing and polyadenylation$460,880
R01 · FY2022 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$385,000
R01 · FY2018 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$385,000
R01 · FY2017 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$385,000
R01 · FY2016 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$385,000
R01 · FY2015 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$377,300
R01 · FY2014 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$250,400
R01 · FY2013 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$385,000
R01 · FY2012 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$385,000
R01 · FY2011 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$336,452
R01 · FY2010 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$336,452
R01 · FY2009 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$336,452
R01 · FY2008 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$336,360
R01 · FY2007 · HL · contact PI
Pathogenesis of hERG Mutations in Human Long QT Syndrome$345,188
R01 · FY2006 · HL · contact PI
Pathogenesis of HERG Mutations in Human Long QT Syndrome$264,250
R01 · FY2005 · HL
Pathogenesis of HERG Mutations in Human Long QT Syndrome$264,250
R01 · FY2004 · HL
Pathogenesis of HERG Mutations in Human Long QT Syndrome$264,250
R01 · FY2003 · HL
Pathogenesis of HERG Mutations in Human Long QT Syndrome$289,250
R01 · FY2002 · HL